Karyopharm Therapeutics Inc. · NASDAQ:KPTI

T. Rowe Price Investment Management, Inc. reported a 11.80% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

T. Rowe Price Investment Management, Inc. reported a 11.80% stake in Karyopharm Therapeutics Inc., 2,244,421 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
11.80%
Shares
2,244,421
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.11.80%2,244,421

Source

View original at SEC

Related